Parameter
| Biomarker | VEGF | Full name | Vascular endothelial growth factor | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognostic assessment, treatment monitoring (potential) |
| Disease | Pleural Mesothelioma | Disease Subtypes | / | ||
| Organ | pleura | Test Sample / Technology Platform | Unspecified specific samples (presumed to be serum and other body fluids) (unspecified specific technology platform) | ||
| Pathobiological Mechanisms | Involved in tumor angiogenesis, promoting PM growth, invasion, and metastasis | ||||
| Clinical Availability Status | Study validation phase: Considered to be a potential prognostic and monitoring biomarker | ||||
| Notes and Dynamics | Relevant studies support its association with PM prognosis, but more validation is needed for clinical application | ||||